Synergistic effect of Indian hedgehog and bone morphogenetic protein-2 gene transfer to increase the osteogenic potential of human mesenchymal stem cells

Stem Cell Research and Therapy

Volumn 4, Issue 5, 2013, Pages

  Reichert, Johannes C ^a   Schmalzl, Jonas ^a   Prager, Patrick ^a   Gilbert, Fabian ^a   Quent, Verena M C ^b   Steinert, Andre F ^a   Rudert, Maximilian ^a   Nöth, Ulrich ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; DNA; OSTEOCALCIN; OSTEOPONTIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA;

ALP GENE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL ACTIVITY; CELL PROLIFERATION; CELL THERAPY; CONTROLLED STUDY; DNA MODIFICATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE INDUCTION; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MARKER GENE; MESENCHYMAL STEM CELL; OC GENE; OP GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RUNX2 GENE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ERINACEIDAE;

ADENOVIRIDAE; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EXTRACELLULAR MATRIX; GENETIC VECTORS; HEDGEHOG PROTEINS; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; TIME FACTORS; TRANSFECTION;

EID: 84883158497     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt316     Document Type: Article

References (42)

1. Bone repair techniques, bone graft, and bone graft substitutes. Perry CR, Clin Orthop Relat Res 1999 360 71 86 10101312
2. Management of posttraumatic segmental bone defects. DeCoster TA, Gehlert RJ, Mikola EA, Pirela-Cruz MA, J Am Acad Orthop Surg 2004 12 28 38 14753795
3. Treating segmental bone defects: a new technique. Clements JR, Carpenter BB, Pourciau JK, J Foot Ankle Surg 2008 47 350 356 10.1053/j.jfas.2008.04.006 18590901
4. Mesenchymal stem cell transplantation to promote bone healing. Gao C, Seuntjens J, Kaufman GN, Tran-Khanh N, Butler A, Li A, Wang H, Buschmann MD, Harvey EJ, Henderson JE, J Orthop Res 2012 30 1183 1189 10.1002/jor.22028 22228593
5. The design and use of animal models for translational research in bone tissue engineering and regenerative medicine. Muschler GF, Raut VP, Patterson TE, Wenke JC, Hollinger JO, Tissue Eng Part B Rev 2010 16 123 145 19891542
6. Engineering anatomically shaped human bone grafts. Grayson WL, Frohlich M, Yeager K, Bhumiratana S, Chan ME, Cannizzaro C, Wan LQ, Liu XS, Guo XE, Vunjak-Novakovic G, Proc Natl Acad Sci USA 2010 107 3299 3304 10.1073/pnas.0905439106 19820164
7. Cell-based bone tissue engineering. Meijer GJ, de Bruijn JD, Koole R, van Blitterswijk CA, PLoS Med 2007 4 9 10.1371/journal.pmed.0040009 17311467
8. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC, J Bone Joint Surg Am 2003 85-A 1544 1552 12925636
9. Hedgehog signaling in animal development: paradigms and principles. Ingham PW, McMahon AP, Genes Dev 2001 15 3059 3087 10.1101/gad.938601 11731473
10. G protein Galphai functions immediately downstream of Smoothened in Hedgehog signalling. Ogden SK, Fei DL, Schilling NS, Ahmed YF, Hwa J, Robbins DJ, Nature 2008 456 967 970 10.1038/nature07459 18987629
11. Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. Sasaki H, Nishizaki Y, Hui C, Nakafuku M, Kondoh H, Development 1999 126 3915 3924 10433919
12. Preclinical and clinical studies on the use of growth factors for bone repair: a systematic review. Fisher DM, Wong JM, Crowley C, Khan WS, Curr Stem Cell Res Ther 2013 8 260 268 10.2174/1574888X11308030011 23317434
13. The synergistic effect of autograft and BMP-7 in the treatment of atrophic nonunions. Giannoudis PV, Kanakaris NK, Dimitriou R, Gill I, Kolimarala V, Montgomery RJ, Clin Orthop Relat Res 2009 467 3239 3248 10.1007/s11999-009- 0846-2 19396502
14. Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: trends, complications, repeat surgery, and charges. Deyo RA, Ching A, Matsen L, Martin BI, Kreuter W, Jarvik JG, Angier H, Mirza SK, Spine 2012 37 222 230 10.1097/BRS.0b013e31821bfa3a 21494195
15. Common molecular pathways in skeletal morphogenesis and repair. Ferguson CM, Miclau T, Hu D, Alpern E, Helms JA, Ann NY Acad Sci 1998 857 33 42 10.1111/j.1749-6632.1998.tb10105.x 9917830
16. Developmental roles and clinical significance of hedgehog signaling. McMahon AP, Ingham PW, Tabin CJ, Curr Top Dev Biol 2003 53 1 114 12509125
17. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. Noth U, Osyczka AM, Tuli R, Hickok NJ, Danielson KG, Tuan RS, J Orthop Res 2002 20 1060 1069 10.1016/S0736-0266(02)00018-9 12382974
18. Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer. Steinert AF, Palmer GD, Pilapil C, Noth U, Evans CH, Ghivizzani SC, Tissue Eng Part A 2009 15 1127 1139 10.1089/ten.tea.2007.0252 18826340
19. Indian hedgehog gene transfer is a chondrogenic inducer of human mesenchymal stem cells. Steinert AF, Weissenberger M, Kunz M, Gilbert F, Ghivizzani SC, Gobel S, Jakob F, Noth U, Rudert M, Arthritis Res Ther 2012 14 168 10.1186/ar3921 22817660
20. Ovine bone- and marrow-derived progenitor cells and their potential for scaffold-based bone tissue engineering applications in vitro and in vivo. Reichert JC, Woodruff MA, Friis T, Quent VM, Gronthos S, Duda GN, Schutz MA, Hutmacher DW, J Tissue Eng Regen Med 2010 4 565 576 10.1002/term.276 20568083
21. Activation of the Hh pathway in periosteum-derived mesenchymal stem cells induces bone formation in vivo: implication for postnatal bone repair. Wang Q, Huang C, Zeng F, Xue M, Zhang X, Am J Pathol 2010 177 3100 3111 10.2353/ajpath.2010.100060 20971735
22. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Hu H, Hilton MJ, Tu X, Yu K, Ornitz DM, Long F, Development 2005 132 49 60 15576404
23. Gene delivery to bone. Evans CH, Adv Drug Deliv Rev 2012 64 1331 1340 10.1016/j.addr.2012.03.013 22480730
24. Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. Spinella-Jaegle S, Rawadi G, Kawai S, Gallea S, Faucheu C, Mollat P, Courtois B, Bergaud B, Ramez V, Blanchet AM, Adelmant G, Baron R, Roman-Roman S, J Cell Sci 2001 114 2085 2094 11493644
25. Hedgehog stimulates only osteoblastic differentiation of undifferentiated KS483 cells. van der Horst G, Farih-Sips H, Lowik CW, Karperien M, Bone 2003 33 899 910 10.1016/j.bone.2003.07.004 14678849
26. Induction of osteogenic differentiation by hedgehog proteins. Nakamura T, Aikawa T, Iwamoto-Enomoto M, Iwamoto M, Higuchi Y, Pacifici M, Kinto N, Yamaguchi A, Noji S, Kurisu K, Matsuya T, Biochem Biophys Res Commun 1997 237 465 469 10.1006/bbrc.1997.7156 9268735
27. Biodegradable poly(epsilon-caprolactone) nanowires for bone tissue engineering applications. Porter JR, Henson A, Popat KC, Biomaterials 2009 30 780 788 10.1016/j.biomaterials.2008.10.022 19012962
28. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Long F, Chung UI, Ohba S, McMahon J, Kronenberg HM, McMahon AP, Development 2004 131 1309 1318 10.1242/dev.01006 14973297
29. Bone anabolic effects of sonic/indian hedgehog are mediated by bmp-2/4-dependent pathways in the neonatal rat metatarsal model. Krishnan V, Ma Y, Moseley J, Geiser A, Friant S, Frolik C, Endocrinology 2001 142 940 947 10.1210/en.142.2.940 11159867
30. Activation of hedgehog signaling inhibits osteoblast differentiation of human mesenchymal stem cells. Plaisant M, Fontaine C, Cousin W, Rochet N, Dani C, Peraldi P, Stem Cells 2009 27 703 713 10.1634/stemcells.2008-0888 19096040
31. Phenotypic changes in dentition of Runx2 homozygote-null mutant mice. Aberg T, Cavender A, Gaikwad JS, Bronckers AL, Wang X, Waltimo-Siren J, Thesleff I, D'Souza RN, J Histochem Cytochem 2004 52 131 139 10.1177/002215540405200113 14688224
32. Transcriptional regulatory cascades in runx2-dependent bone development. Liu TM, Lee EH, Tissue Eng Part B Rev 2013 19 254 263 10.1089/ten.teb.2012.0527 23150948
33. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G, Cell 1997 89 747 754 10.1016/S0092-8674(00)80257-3 9182762
34. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. Kern B, Shen J, Starbuck M, Karsenty G, J Biol Chem 2001 276 7101 7107 10.1074/jbc.M006215200 11106645
35. Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Price PA, Otsuka AA, Poser JW, Kristaponis J, Raman N, Proc Natl Acad Sci USA 1976 73 1447 1451 10.1073/pnas.73.5.1447 1064018
36. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G, Bone 1998 23 187 196 10.1016/S8756-3282(98)00092-1 9737340
37. Bone sialoprotein. Ganss B, Kim RH, Sodek J, Crit Rev Oral Biol Med 1999 10 79 98 10.1177/10454411990100010401 10759428
38. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farach-Carson MC, Mintz KA, Robey PG, Teitelbaum SL, Cheresh DA, J Biol Chem 1993 268 9901 9907 8486670
39. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model. Zhang JH, Tang J, Wang J, Ma W, Zheng W, Yoneda T, Chen J, Int J Oncol 2003 23 1043 1048 12963984
40. Progress and Prospects: genetic treatments for disorders of bones and joints. Evans CH, Ghivizzani SC, Robbins PD, Gene Ther 2009 16 944 952 10.1038/gt.2009.73 19675584
41. Adenoviral vectors for gene therapy. Douglas JT, Mol Biotechnol 2007 36 71 80 10.1007/s12033-007-0021-5 17827541
42. Gene therapy for bone healing. Evans CH, Expert Rev Mol Med 2010 12 18 20569532